The Oasis Health Journal · Submitted September 2, 2026 · 3:01 PM EDT
By June Mackerel · Edited by Colette Ward
Listen · June Mackerel reads this piece · 1:52
The supplement industry has been remarkably consistent on one point for approximately two decades now: omega-3 omega-6 balance supplements are essential in a very particular ratio. One to four, they say. Or one to two. Or one to one, depending on whom you ask and what they happen to be selling that week. The precise number shifts, but the certainty does not.
The research, I am afraid, has been rather less convinced.
What the Lupus Review Actually Found About Fish Oil Supplement Ratio
A 2026 scoping review published in Advances in Nutrition examined dietary and nutritional factors in systemic lupus erythematosus, a complex autoimmune disease in which the body's immune system rather unhelpfully attacks its own tissues. The reviewers analysed 139 studies published between 2012 and 2023, covering human trials, animal models and in-vitro work. It was thorough.
The findings on omega-3 fatty acids were encouraging: higher intake was consistently linked to reduced inflammatory markers and improved patient-reported outcomes. The bit about ratios, however, was rather less impressive. The review noted that a higher omega-6 to omega-3 ratio correlated with worsened disease activity, which sounds damning until you read the next sentence.
That correlation, the authors noted, disappeared when researchers controlled for total polyunsaturated fat intake.
The ratio, in other words, was not describing a harmful imbalance. It was describing people who ate very little omega-3 in the first place. The problem was not proportion. The problem was scarcity.
The Case-Control Study That Forgot to Care About Ratios
A 2026 case-control study published in Endocrinology, Diabetes and Metabolism enrolled 225 newly diagnosed adults with non-alcoholic fatty liver disease and 450 controls, all aged twenty to sixty. Researchers assessed dietary intake and calculated something called the UK Dietary Reference Values index, which awards points for eating things the government thinks you ought to eat and deducts points for eating things it wishes you would not.
Higher scores on the index were associated with lower odds of the disease. Each one-standard-deviation increase in the index corresponded to a 28 percent reduction in odds, after adjusting for age, sex, physical activity and other confounders.

The protective components included fruits, vegetables and fish. Higher fish intake, specifically, was linked to lower disease risk. The study did not calculate anyone's omega-6 to omega-3 ratio, measure fish oil supplement use or ask participants what they thought about polyunsaturated fat intake. Apparently nobody felt the need.
The Cycling Review's Entirely Sensible Omega Recommendations
A 2026 review in the Journal of the International Society of Sports Nutrition assessed the evidence base for supplements used to enhance cycling performance. The section on omega-3 supplements was admirably brief. The authors classified omega-3 fatty acids as a medical supplement with an indirect performance benefit, primarily through supporting recovery, managing inflammation and maintaining immune function.
They did not mention ratios.
They did not suggest cyclists calculate their polyunsaturated fat intake down to the gram, consult a spreadsheet or purchase anything labelled 'balanced'. They recommended omega-3 supplementation for athletes as a sensible measure to support adaptation to training. Then they moved on to the next topic, which was pickle juice. I am not making that up.
Why We Got Obsessed With the Ratio in the First Place
The omega-6 to omega-3 ratio became popular in the early 2000s, largely on the strength of a hypothesis: modern Western diets contain far more omega-6 than omega-3, and that imbalance drives inflammation. It was a tidy story. Omega-6 fatty acids are precursors to pro-inflammatory eicosanoids; omega-3 fatty acids are precursors to anti-inflammatory ones. If someone eats too much of one and not enough of the other, the reasoning went, the whole system tips in the wrong direction.
The hypothesis was plausible. The evidence, however, has been rather more equivocal. Some observational studies found associations between higher ratios and worse health outcomes, but those studies also found that people with high ratios simply were not eating much omega-3. The ratio was a symptom, not a cause.
Intervention trials, meanwhile, have been spectacularly uninterested in the ratio. Most simply give people more omega-3 and measure what happens. What happens, generally, is that inflammatory markers go down and various metabolic and cardiovascular outcomes improve. Nobody has yet demonstrated that the same benefit can be achieved by reducing omega-6 intake while holding omega-3 constant, which one might expect if the ratio were actually the mechanism.
One imagines there was a meeting at some point, possibly in a hotel conference room with inadequate lighting and too much coffee, where someone decided the ratio was terrifically important. It is not clear what the evidence was. It is even less clear why the idea stuck.
What to Do If the Ratio Has Already Been Calculated
If someone has already gone to the trouble of working out their omega-6 to omega-3 ratio, they have my admiration. It requires weighing food, consulting databases and keeping track of cooking oils, which is the sort of commitment one usually reserves for a hobby or a grudge.
The good news is it does not need to be done again.
The simpler approach, according to the evidence we actually have, is to eat more omega-3. Fatty fish two or three times a week is the usual recommendation. If that is not practical, fish oil or algae oil supplements are a reasonable substitute. The typical pufa supplement dosage in most trials is one to two grams of combined EPA and DHA daily. The exact amount depends on what someone is trying to achieve and what else they are eating, but the range of effective doses in most trials is fairly forgiving.
Omega-6 intake does not need to be reduced unless someone is currently eating quite a lot of it, and even then the issue is probably not the omega-6 itself but whatever else comes with it: fried food, processed snacks, meals assembled from ingredients that do not spoil. Omega-6 from whole foods, nuts, seeds and the like, has not been shown to cause problems. The ratio obsession, in practice, mostly creates anxiety and sells supplements with impressive labels.
The lupus review, to its credit, was refreshingly blunt on this point: the evidence supports omega-3 supplementation. It does not support calculating ratios, adjusting for omega-6 or purchasing anything marketed as 'balanced'. The protective effect comes from having enough omega-3. That is the whole story.
One might ask why the supplement industry continues to emphasise balance when the research emphasises sufficiency. One might ask, but one suspects the answer is not terribly complicated.
This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.
Sources
- An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists, Journal of the International Society of Sports Nutrition (2026).
- A comprehensive review of the physiology and evidence base to guide the use of ergogenic and medical supplements for enhanced cycling performance, Journal of the International Society of Sports Nutrition (2026).
- Gut microbiota in early and established stages of rheumatoid arthritis: from pathogenesis to promising prevention and treatment, Annals of medicine (2026).
- Adherence to UK Dietary Reference Values and Lower Odds of Non-Alcoholic Fatty Liver Disease: A Secondary Analysis of a Case-Control Study, Endocrinology, diabetes & metabolism (2026).
- Dietary and Nutritional Factors in Systemic Lupus Erythematosus Pathophysiology: A Scoping Review of the Evidence from In Vitro, In Vivo, and Human Studies, Advances in nutrition (Bethesda, Md.) (2026).

Leave a comment